Evidence map›Paper›PMID 41332071›Full record

ArticleInternational journal of surgery case reports2025

Aggressive clitoral angiomyxoma mimicking bartholinits: A case report and review of the literature.

Hanane Houmaid, Myriem Sali, Karam Harou, Bouchra Fakhir, Hamid Asmouki, Abderraouf Soummani

Abstract readCase Reports
In one paragraph

Article in International journal of surgery case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hanane HoumaidGynecology-Obstetrics Department, Cadi Ayyad University Faculty of Medicine and Pharmacy of Marrakech, Morocco. Electronic address: h.houmaid@uca.ac.ma.
Myriem SaliGynecology-Obstetrics Department, Cadi Ayyad University Faculty of Medicine and Pharmacy of Marrakech, Morocco. Electronic address: myrsali806@gmail.com.
Karam HarouGynecology-Obstetrics Department, Cadi Ayyad University Faculty of Medicine and Pharmacy of Marrakech, Morocco. Electronic address: drharou@gmail.com.
Bouchra FakhirGynecology-Obstetrics Department, Cadi Ayyad University Faculty of Medicine and Pharmacy of Marrakech, Morocco. Electronic address: fakhirb@gmail.com.
Hamid AsmoukiGynecology-Obstetrics Department, Mohammed VI Hospital, Caddi Ayyad University, Marrakech, Morocco. Electronic address: asmouki@gmail.com.
Abderraouf SoummaniGynecology-Obstetrics Department, Cadi Ayyad University Faculty of Medicine and Pharmacy of Marrakech, Morocco. Electronic address: asoummani@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and importanceAggressive angiomyxoma is a rare, slow-growing mesenchymal tumor typically found in the vulvo-perineal and pelvic region of women of reproductive age. Its benign but locally invasive nature and high recurrence rate make accurate diagnosis and management challenging. This case highlights a common diagnostic pitfall and underscores the importance of imaging and histopathological confirmation. PRESENTATION OF CASE: A 32-year-old woman presented to the emergency department with a painful vulvar mass initially diagnosed as bartholinitis. Magnetic resonance imaging (MRI) revealed a well-limited mass in the left labia majora extending to the clitoris. Initial surgical excision resulted in an R2 margin, confirmed by histopathology to be aggressive angiomyxoma. The patient underwent a mandatory surgical revision, achieving R0 excision. The postoperative course was uneventful, with a good outcome at the six-month follow-up. CLINICAL DISCUSSION: This case illustrates the propensity for aggressive angiomyxoma to be misdiagnosed as more common conditions like Bartholin's gland cysts. MRI is the imaging modality of choice for characterizing the lesion and planning surgery. Complete surgical excision (R0) is the cornerstone of treatment to minimize the high risk of local recurrence. Hormonal therapy with GnRH analogues can be considered as an adjuvant treatment.

conclusionAggressive angiomyxoma is a rare pathology that requires a high index of suspicion. Management should be undertaken in specialized centers with expertise in soft tissue tumors to ensure complete resection and manage potential recurrences. Increased awareness among clinicians is crucial for early diagnosis and appropriate treatment.

Indexed as

Aggressive angiomyxomaCase reportPathological confirmationSurgical treatmentVulvar mass

Identifiers

PMID41332071
PMCPMC12555875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.